41761-00-6

Basic information

• Product Name: methyl phenylchlorophosphonate
• Synonyms: methyl phenylchlorophosphonate;Phenylphosphonochloridic acid methyl ester
• CAS NO: 41761-00-6
• Molecular Formula: C₇H₈ClO₂P
• Molecular Weight: 206.563381
• EINECS: 255-539-6
• Mol File: 41761-00-6.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 246.2°C at 760 mmHg
• Flash Point: 104.5°C
• Appearance: /
• Density: 1.26g/cm³
• Vapor Pressure: 0.0431mmHg at 25°C
• Refractive Index: 1.506
• CAS DataBase Reference: methyl phenylchlorophosphonate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl phenylchlorophosphonate(41761-00-6)
• EPA Substance Registry System: methyl phenylchlorophosphonate(41761-00-6)

Safety Data

• Hazardous Substances Data: 41761-00-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C7H8ClO2P/c1-10-11(8,9)7-5-3-2-4-6-7/h2-6H,1H3

Upstream product

• 10113-28-7 dimethyl phenyl phosphate 
• 2240-41-7 dimethyl phenylphosphonate 
• 644-97-3 Dichlorophenylphosphine 
• 20180-12-5 phenyl-selenophosphonsaeure-dimethylester 
• 824-72-6 P,P-dichlorophenylphosphine oxide 
• 67-56-1 methanol 

Downstream Products

• 65111-17-3 C₁₁H₁₈NO₂P 
• 63581-56-6 N,N-dimethylphenylphosphonamide tetramethylammonium salt 
• 1464720-99-7 (E)-ethyl 3-(2-(dimethoxyphosphoryl)phenyl)acrylate 
• 7162-15-4 methyl phenylphosphinate 
• 10088-45-6 methyl phenylphosphonic acid 
• 200941-06-6 C₂₆H₂₈NO₆P 
• 2240-41-7 dimethyl phenylphosphonate 
• 65111-15-1 P-methoxyl-N-methyl-P-phenylphosphonic amide 
• 38938-30-6 methyl N-isopropyl P-phenylphosphonamidate 
• 55215-28-6 methyl N,N-(dimethyl)phenylphosphonamidate 
• 65111-16-2 methyl N-ethyl-P-phenylphosphonamidate 

Relevant articles and documents

PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF

The present invention provides a phosphorus-containing compound characterized by being a compound represented by the following structure: the compound is a novel immune cell migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immune cell migration and can relieve the symptoms of most dry-eye patients.

Double role of the hydroxy group of phosphoryl in palladium(II)-catalyzed ortho -olefination: A combined experimental and theoretical investigation

Density functional theory calculations have been carried out on Pd-catalyzed phosphoryl-directed ortho-olefination to probe the origin of the significant reactivity difference between methyl hydrogen benzylphosphonates and dimethyl benzylphosphonates. The overall catalytic cycle is found to include four basic steps: C-H bond activation, transmetalation, reductive elimination, and recycling of catalyst, each of which is constituted from different steps. Our calculations reveal that the hydroxy group of phosphoryl plays a crucial role almost in all steps, which can not only stabilize the intermediates and transition states by intramolecular hydrogen bonds but also act as a proton donor so that the η1-CH3COO- ligand could be protonated to form a neutral acetic acid for easy removal. These findings explain why only the methyl hydrogen benzylphosphonates and methyl hydrogen phenylphosphates were found to be suitable reaction partners. Our mechanistic findings are further supported by theoretical prediction of Pd-catalyzed ortho-olefination using methyl hydrogen phenylphosphonate, which is verified by experimental observations that the desired product was formed in a moderate yield.

Evaluation of phosphorus-containing inhibitors of γ-glutamyl hydrolase

Several putative, phosphorus-containing inhibitors of γ-glutamyl hydrolase were synthesized and evaluated for inhibitory activity. The phosphonamidoic acids were shown to be weak competitive inhibitors while both a phosphoramidate diester and a phosphonamidate ester were shown to be potent time-dependent inactivators, presumably through irreversible phosphorylation of an active site nucleophile.